Stockscreener 앱 받기
17.84
0.50%
-0.09
시간 외 거래:
18.00
0.16
+0.90%
전일 마감가:
$17.93
열려 있는:
$17.78
하루 거래량:
2.06M
Relative Volume:
3.39
시가총액:
$1.12B
수익:
$330.50M
순이익/손실:
$145.42M
주가수익비율:
7.8938
EPS:
2.26
순현금흐름:
$157.96M
1주 성능:
-3.98%
1개월 성능:
-6.84%
6개월 성능:
+11.01%
1년 성능:
+11.71%
1일 변동 폭
$17.76
$18.15
1주일 범위
$17.76
$18.69
52주 변동 폭
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
명칭
Innoviva Inc
전화
(650) 238-9600
주소
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
INVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
17.84 | 1.12B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 개시 | Goldman | Neutral |
| 2017-11-20 | 개시 | Deutsche Bank | Hold |
Innoviva Inc 주식(INVA)의 최신 뉴스
Wellington Management Group LLP Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by HighTower Advisors LLC - Defense World
Innoviva, Inc.'s (NASDAQ:INVA) Popularity With Investors Is Under Threat From Overpricing - Simply Wall St
Oversold Conditions For Innoviva (INVA) - Nasdaq
Innoviva, Inc. (NASDAQ:INVA) Short Interest Down 7.5% in November - Defense World
Innoviva enters distribution, license agreement with Basilea for Zevtera - Yahoo Finance
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole) - BioSpace
Innoviva seals deal for new MRSA antibiotic in the US - Investing.com
Innoviva Secures Exclusive Rights to Groundbreaking MRSA Antibiotic Zevtera in Major FDA-Approved Drug Deal - StockTitan
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera(R) (ceftobiprole) in the United States - Marketscreener.com
Basilea announces agreement with Innoviva Specialty - GlobeNewswire
Basilea Announces Agreement with Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera (Ceftobiprole) in the United States - Marketscreener.com
How To Trade (INVA) - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 22,961 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Walleye Capital LLC Purchases Shares of 11,066 Innoviva, Inc. (NASDAQ:INVA) - Defense World
Charles Schwab Investment Management Inc. Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Charles Schwab Investment Management Inc. Has $14.14 Million Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Systematic Financial Management LP Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Redwood Investment Management LLC Sells 41,852 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Thrivent Financial for Lutherans Sells 2,384 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva to Participate in the Citi 2024 Global Healthcare Conference - BioSpace
Innoviva, Inc. (NASDAQ:INVA) Stake Reduced by Westfield Capital Management Co. LP - MarketBeat
Segall Bryant & Hamill LLC Makes New $715,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Victory Capital Management Inc. Grows Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Jennison Associates LLC - MarketBeat
When (INVA) Moves Investors should Listen - Stock Traders Daily
Pacer Advisors Inc. Sells 547,610 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Principal Financial Group Inc. Sells 20,058 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Empowered Funds LLC Has $1.85 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva Reports Strong Q3 Growth Amidst Strategic Advances - TipRanks
US Bancorp DE Has $56,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Learn to Evaluate (INVA) using the Charts - Stock Traders Daily
INVA stock touches 52-week high at $20.38 amid robust gains - Investing.com Australia
Innoviva to Participate in the UBS Global Healthcare Conference - Business Wire
Innoviva (NASDAQ:INVA) Hits New 52-Week HighHere's What Happened - MarketBeat
CWA Asset Management Group LLC Purchases Shares of 29,710 Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
New York State Teachers Retirement System Sells 1,500 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Reports Strong Third Quarter 2024 Financial Results; Highlights Recent Company Progress - Defense World
State of Alaska Department of Revenue Sells 846 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Third Quarter 2024 Earnings: EPS: US$0.019 (vs US$1.26 in 3Q 2023) - Yahoo Finance
Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva: Q3 Earnings Snapshot - San Antonio Express-News
Innoviva earnings missed by $0.25, revenue topped estimates - Investing.com UK
Creative Planning Boosts Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Louisiana State Employees Retirement System Sells 1,000 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Q3 Revenue Surges 68% in US Sales Despite Earnings Drop; Prix Galien Nomination - StockTitan
Innoviva, Inc. (NASDAQ:INVA) Shares Acquired by Harbor Capital Advisors Inc. - MarketBeat
When the Price of (INVA) Talks, People Listen - Stock Traders Daily
Allspring Global Investments Holdings LLC Sells 4,700 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Assenagon Asset Management S.A. Decreases Stock Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva Inc (INVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):